13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
ISSUER PROFILE · CIK 0001439222 · CUSIP 00847X104

Agios Pharmaceuticals, Inc.AGIO

4 13D/G filings 3 distinct filers 0 insider transactions (365d)

Cross-Reference Snapshot

Activist filings
4
1 SCHEDULE 13G · 3 SC
Distinct filers
3
multi-activist cluster
Insiders (365d)
0
0 buys · 0 sales
Latest short DTC
6.44
as of 2026-09-30

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $5.44M
Point72 Asset Mgmt

13D/G Filings Timeline · 4 total

FiledFormFilerStakeSharesIntent
2026-07-02 SCHEDULE 13G D. E. SHAW & CO, L.P. — — view →
2021-04-05 SC BRISTOL MYERS SQUIBB CO — — view →
2019-11-14 SC Celgene European Investment Co LLC — — view →
2018-01-23 SC Celgene European Investment Co LLC — — view →

FINRA Short Interest History

SettlementShort InterestDays to Cover% Δ vs prior
2026-09-30 7,016,166 6.44 -7.2%
2026-09-15 7,557,252 9.46 +0.3%
2026-08-31 7,535,054 8.44 -1.2%
2026-08-14 7,629,012 6.99 +11.5%
2026-07-31 6,840,722 5.14 +3.2%
2026-07-15 6,630,197 6.42 -1.9%
2026-06-30 6,756,481 5.08 -2.1%
2026-06-15 6,898,306 6.62 -0.4%
2026-05-29 6,926,807 8.16 -7.0%
2026-05-15 7,450,870 8.67 +6.8%
2026-04-30 6,974,194 4.18 -1.5%
2026-04-15 7,082,292 6.95 +7.2%

Alert me when any activist files on Agios Pharmaceuticals, Inc.

Free. We email you when criteria match. One-click unsubscribe in every email.

Track every activist who touches this name.

Custom alerts · full feed · daily intelligence · API. From $49/mo.

See pricing →